For the quarter ending 2026-03-31, ISPC had -$4,061,846 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues from external customers | - | 51,761 | 106,592 | - |
| Cost of revenue, excluding amortization | - | 550,950 | 156,704 | - |
| Technology expenses, excluding amortization | - | 184,314 | 158,386 | - |
| Sales and marketing expenses | - | 549,077 | 1,140,902 | - |
| Supply development expenses | - | 31,835 | 215,144 | - |
| Fulfillment expenses | - | 131,729 | 153,781 | - |
| Other segment items | - | 3,196,522 | 799,722 | - |
| Depreciation & amortization expense | - | 407,731 | 457,730 | - |
| Interest expense | - | 1 | 2 | - |
| Interest income | - | 271 | 3,477 | - |
| Interest and penalties on sales tax liability | - | 1,118 | -2,069 | - |
| Net loss | -2,275,221 | -5,001,245 | -2,780,648 | -2,705,639 |
| Stock-based compensation expense | 1,028 | 1,765 | 1,797 | 17,704 |
| Amortization of internally developed software | 133,536 | 342,719 | 392,718 | 735,436 |
| Depreciation of property and equipment | 2,409 | 17,123 | 17,123 | 34,228 |
| Bad debt expense | 368 | 45,806 | -3,521 | 17,578 |
| Write-off of other intangible assets | - | 525,145 | - | - |
| Amortization of other intangible assets | - | 47,889 | 47,889 | 95,777 |
| Amortization of discount and debt issuance costs on senior note payable | - | - | 0 | - |
| Write-off of accounts receivable unbilled | - | 0 | - | - |
| Write-off of accounts payable | - | -75,000 | - | - |
| Non-cash interest income related to accretion of discount on available-for-sale securities | - | 0 | 0 | 0 |
| Write-off of internally developed software | - | 1,871,064 | - | - |
| Gain on debt settlement | 261,525 | - | - | - |
| Loss from sales of available-for-sale securities | - | 0 | 0 | 0 |
| Accounts receivable | 84,918 | -26,827 | -255,059 | -1,054,589 |
| Loss on disposal of property and equipment | - | 0 | 0 | - |
| Inventory | - | -45,110 | - | - |
| Accounts receivable unbilled | - | 0 | 0 | 0 |
| Prepaid expenses and other current assets | 506,735 | -627,555 | 493,196 | -59,966 |
| Operating lease right-of-use asset | 15,246 | 14,986 | 14,855 | 28,976 |
| Accounts payable | -393,686 | 666,578 | 456,016 | 117,449 |
| Accrued expenses | 24,261 | -97,636 | 71,311 | -523,219 |
| Operating lease liability | -13,809 | -12,638 | -6,449 | -24,282 |
| Security deposit | - | 0 | 0 | - |
| Deferred revenue | -2,800 | 37,029 | -8,560 | -196,642 |
| Net cash used in operating activities | -3,361,846 | -916,923 | -2,035,606 | -1,288,079 |
| Purchase of property and equipment | - | 0 | 0 | 454 |
| Capitalization of intangible asset under development | - | 0 | 1,000,000 | 0 |
| Purchase of leasehold improvements included in operating lease right-of-use asset | - | 0 | 0 | - |
| Purchase of available-for-sale securities | - | 0 | 0 | 0 |
| Proceeds from sales and maturities of available-for-sale securities | - | 0 | 0 | 0 |
| Net cash used in investing activity | -700,000 | 0 | -1,000,000 | -454 |
| Proceeds from issuance of common stock in connection with underwritten offering | - | - | 3,999,574 | - |
| Proceeds from issuance of common stock in with securities purchase agreement | - | 2,249,576 | 1,751,098 | -1,100 |
| Proceeds from issuance of common stock in connection with private placement | - | 1,749,998 | - | - |
| Payment of offering costs in connection with the completed financings | - | - | -521,083 | - |
| Proceeds from issuance of series c convertible preferred stock in connection with pipe financing | - | 5,500,000 | - | - |
| Repurchase of common stock purchase warrants exercisable under pipe warrants | - | - | - | 0 |
| Proceeds from issuance of senior note payable | - | - | 0 | - |
| Payment of offering costs in connection with the issuance of common stock in connection with pre-funded warrants and common shares | - | 1,006,083 | - | - |
| Proceeds from issuance of common stock in connection with at the market offering agreement | - | 0 | 0 | 0 |
| Payment of debt issuance costs in connection with senior note payable | - | - | 0 | - |
| Proceeds from pre-funded warrants | - | 0 | - | - |
| Payment of offering costs in connection with the issuance of common stock in connection with at the market offering agreement | - | 0 | 0 | 0 |
| Repurchase of common stock purchase warrants exercisable under pipe warrants | - | 0 | 0 | - |
| Net cash provided by financing activities | - | 5,015,000 | 5,229,589 | -1,100 |
| Net increase (decrease) in cash and cash equivalents | - | 4,098,077 | - | - |
| Net decrease in cash and cash equivalents | -4,061,846 | 4,098,077 | 2,193,983 | -1,289,633 |
| Cash and cash equivalents at beginning of period | 6,880,835 | 2,782,758 | 1,878,408 | - |
| Cash and cash equivalents at end of period | 2,818,989 | 6,880,835 | 2,782,758 | - |
iSpecimen Inc. (ISPC)
iSpecimen Inc. (ISPC)